These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 5898299)

  • 1. [Biochemical pharmacological studies of the coronary dilator 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromene)-hydrochloride. 1. Methods for determination of the substance and its metabolites in plasma, tissues and urine].
    Klarwein M; Nitz RE
    Arzneimittelforschung; 1965 May; 15(5):555-8. PubMed ID: 5898299
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic and coronary hemodynamic effects of 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromene)-hydrochloride (Intensain, A-27053).
    Rowe GG; McKenna DH; Sialer S; Corliss RJ
    Vasc Dis; 1967 Jun; 4(3):183-90. PubMed ID: 6028828
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic and coronary hemodynamic effects of 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromene)-hydrochloride (Intensain, A-27053).
    Rowe GG; Terry W; Stenlund RR; Thomsen JH; Querimit AS
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):99-103. PubMed ID: 5353477
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of new vasoactive drug, 3(beta-diethylamino-ethyl)-4-methyl-7-(carbethoxy-methoxy)-2-oxy-1,2-chromen HC1 (Intensain) on the coronary circulation in dogs].
    Campus S; Pandolfo G; Dessy P; Gagna C; Uslenghi E
    Minerva Cardioangiol; 1967 Nov; 15(11):722-4. PubMed ID: 5616009
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacodynamic studies after short- and long-term treatment with radioactively labelled 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-2-oxo-(1,2-chromene)-hydrochloride in animal experiments].
    Möllmann H; Alfes H; Schraven E; Ostrowski J; Nitz RE; Bigalke C
    Arzneimittelforschung; 1972 Aug; 22(8):1242-50. PubMed ID: 4629173
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacodynamic effect on coronary blood circulation and metabolism of the human heart. Studies with 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromen)-hydrochloride].
    Rudolph W; Meixner L; Künzig HJ
    Klin Wochenschr; 1967 Apr; 45(7):333-53. PubMed ID: 5585313
    [No Abstract]   [Full Text] [Related]  

  • 7. Disposition and metabolism of fenbufen in several laboratory animals.
    Chiccarelli FS; Eisner HJ; Van Lear GE
    Arzneimittelforschung; 1980; 30(4A):707-15. PubMed ID: 6776965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacodynamic aspects of a new coronary dilator: (3,4,5, trimethoxycinnamoil)-1 (ethylacetate)-4-piperazine maleate (6753)].
    Marmo E; Caputi A
    Boll Soc Ital Cardiol; 1971; 16(9):523-30. PubMed ID: 5150376
    [No Abstract]   [Full Text] [Related]  

  • 9. [Protracted coronary vasodilator effect of 3-(2-diethylaminoethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-1.2-chromene].
    FIEGEL G; KELLING HW; BARGHEER R; KUKWA D
    Med Welt; 1963 Apr; 17():976-9. PubMed ID: 13945047
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 2: General pharmacological properties.
    Zwagemakers JM; Claassen V
    Arzneimittelforschung; 1980; 30(9):1526-34. PubMed ID: 7193021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacology of diphenylalkyl derivatives. I. Comparative studies of coronary dilator diphenylalkylamine derivatives.
    Leszkovszky G; Tardos L; Erdély I; Harsányi K
    Acta Physiol Acad Sci Hung; 1966; 29(3):283-97. PubMed ID: 5923039
    [No Abstract]   [Full Text] [Related]  

  • 12. The fate of amezinium in humans and animals.
    Traut M; Kummer H; Brode E
    Arzneimittelforschung; 1981; 31(9a):1616-22. PubMed ID: 7197976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of 3-(2-diethylaminoethyl)-4-methyl-7-carbethoxymethoxy-2-oxo-(1,2-chromene), a selective coronary dilator agent, on circulation, respiration and metabolism].
    BRETSCHNEIDER HJ; EBERLEIN HJ; KABUS HM; NELLE G; REICHMANN W
    Arzneimittelforschung; 1963 Apr; 13():255-68. PubMed ID: 14015321
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacological effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, a new, antihypertensive substance].
    Hoefke W; Kobinger W
    Arzneimittelforschung; 1966 Aug; 16(8):1038-50. PubMed ID: 6014885
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
    Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A
    Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]- 4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor: I. biochemical and pharmacological characterization.
    Emonds-Alt X; Proietto V; Steinberg R; Oury-Donat F; Vigé X; Vilain P; Naline E; Daoui S; Advenier C; Le Fur G; Maffrand JP; Soubrié P; Pascal M
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1171-9. PubMed ID: 12438541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On the pharmacology of the active ingredients of Ginkgo biloba].
    Peter H; Fisel J; Weisser W
    Arzneimittelforschung; 1966 Jun; 16(6):719-25. PubMed ID: 6014582
    [No Abstract]   [Full Text] [Related]  

  • 18. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.
    Laubie M; Schiavi P; Vincent M; Schmitt H
    J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biotransformation of tramadol in man and animal (author's transl)].
    Lintz W; Erlaçin S; Frankus E; Uragg H
    Arzneimittelforschung; 1981; 31(11):1932-43. PubMed ID: 7198474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.